Pascal Rigollier

1.5k total citations
15 papers, 515 citations indexed

About

Pascal Rigollier is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pascal Rigollier has authored 15 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Organic Chemistry and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pascal Rigollier's work include Receptor Mechanisms and Signaling (4 papers), Asymmetric Synthesis and Catalysis (3 papers) and Computational Drug Discovery Methods (3 papers). Pascal Rigollier is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Asymmetric Synthesis and Catalysis (3 papers) and Computational Drug Discovery Methods (3 papers). Pascal Rigollier collaborates with scholars based in Switzerland, United States and Austria. Pascal Rigollier's co-authors include Walter Schilling, Yasuchika Yamaguchi, Steven Whitebread, Michele Chiesi, Leoluca Criscione, Mary W. Walker, H. Rüeger, Christine Batzl‐Hartmann, Philip Magnus and Rainer O. Heurich and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Journal of Medicinal Chemistry.

In The Last Decade

Pascal Rigollier

15 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Rigollier Switzerland 11 269 179 158 122 81 15 515
H. Rüeger Switzerland 11 435 1.6× 213 1.2× 254 1.6× 114 0.9× 72 0.9× 17 841
Helmut Wittneben Germany 5 288 1.1× 197 1.1× 138 0.9× 38 0.3× 32 0.4× 6 498
Laurie Tota United States 17 598 2.2× 133 0.7× 339 2.1× 70 0.6× 50 0.6× 25 1.1k
Horst Dollinger Germany 7 207 0.8× 170 0.9× 72 0.5× 47 0.4× 66 0.8× 12 382
Kerry L. Chapman United Kingdom 12 279 1.0× 193 1.1× 112 0.7× 26 0.2× 21 0.3× 21 469
Thuy-Anh Tran United States 11 206 0.8× 50 0.3× 105 0.7× 114 0.9× 17 0.2× 15 378
Sébastien Dilly Belgium 14 256 1.0× 108 0.6× 147 0.9× 21 0.2× 40 0.5× 38 477
David L. Saussy United States 11 368 1.4× 195 1.1× 79 0.5× 16 0.1× 26 0.3× 23 587
П.В. Ершов Russia 14 229 0.9× 67 0.4× 58 0.4× 16 0.1× 46 0.6× 63 547
Michael Ankersen Denmark 16 399 1.5× 147 0.8× 209 1.3× 586 4.8× 60 0.7× 38 1.2k

Countries citing papers authored by Pascal Rigollier

Since Specialization
Citations

This map shows the geographic impact of Pascal Rigollier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Rigollier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Rigollier more than expected).

Fields of papers citing papers by Pascal Rigollier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Rigollier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Rigollier. The network helps show where Pascal Rigollier may publish in the future.

Co-authorship network of co-authors of Pascal Rigollier

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Rigollier. A scholar is included among the top collaborators of Pascal Rigollier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Rigollier. Pascal Rigollier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Velcicky, Juraj, Casey J. N. Mathison, V. I. Nikulin, et al.. (2019). Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors. ACS Medicinal Chemistry Letters. 10(6). 887–892. 9 indexed citations
2.
Velcicky, Juraj, Ursula Bodendorf, Pascal Rigollier, et al.. (2018). Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo. Journal of Medicinal Chemistry. 61(3). 865–880. 20 indexed citations
3.
Boettcher, Andreas, Simon Ruedisser, P. Erbel, et al.. (2010). Fragment-Based Screening by Biochemical Assays: Systematic Feasibility Studies with Trypsin and MMP12. SLAS DISCOVERY. 15(9). 1029–1041. 29 indexed citations
4.
Cole, Andrew G., Axel Metzger, Kurt W. Saionz, et al.. (2010). A facile synthesis of novel 2-amino-6-arylmethyl-7-carboxamido-7,8-dihydropyrimido[5,4-f][1,4]thiazepin-5-ones. Tetrahedron Letters. 51(34). 4486–4489. 3 indexed citations
6.
Göschke, Richard, Stefan Stutz, Vittorio Rasetti, et al.. (2007). Novel 2,7-Dialkyl-Substituted 5(S)-Amino-4(S)-hydroxy-8-phenyl-octanecarboxamide Transition State Peptidomimetics Are Potent and Orally Active Inhibitors of Human Renin. Journal of Medicinal Chemistry. 50(20). 4818–4831. 34 indexed citations
7.
Jacoby, Edgar, Ansgar Schuffenhauer, Khalil Azzaoui, et al.. (2005). Key Aspects of the Novartis Compound Collection Enhancement Project for the Compilation of a Comprehensive Chemogenomics Drug Discovery Screening Collection. Current Topics in Medicinal Chemistry. 5(4). 397–411. 51 indexed citations
8.
Rueeger, Heinrich, Marc Gerspacher, Pascal Rigollier, et al.. (2004). Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(10). 2451–2457. 16 indexed citations
9.
Rueeger, Heinrich, Pascal Rigollier, Yasuchika Yamaguchi, et al.. (2000). Design, synthesis and SAR of a series of 2-substituted 4-amino-quinazoline neuropeptide Y Y5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 10(11). 1175–1179. 37 indexed citations
10.
Criscione, Leoluca, Pascal Rigollier, Christine Batzl‐Hartmann, et al.. (1998). Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.. Journal of Clinical Investigation. 102(12). 2136–2145. 183 indexed citations
11.
Magnus, Philip, et al.. (1998). Applications of the β-Azidonation Reaction to Organic Synthesis. α,β-Enones, Conjugate Addition, and γ-Lactam Annulation. Journal of the American Chemical Society. 120(48). 12486–12499. 20 indexed citations
12.
Magnus, Philip, et al.. (1993). New trialkylsilyl enol ether chemistry: intramolecular [2 + 2] cyclizations of .beta.-amido triisopropylsilyl enol ethers. Journal of the American Chemical Society. 115(26). 12629–12630. 8 indexed citations
13.
Magnus, Philip & Pascal Rigollier. (1992). New mild methodology for the synthesis of α-phenylthio and α-phenylseleno ketones. Tetrahedron Letters. 33(41). 6111–6114. 10 indexed citations
14.
Rigollier, Pascal, et al.. (1991). ChemInform Abstract: Regioselective Cyclopentane Ring Formation Mediated by Titanocene Chloride.. ChemInform. 22(12). 1 indexed citations
15.
Rigollier, Pascal, et al.. (1990). Regioselective cyclopentane ring formation mediated by titanocene chloride. Journal of the American Chemical Society. 112(25). 9441–9442. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026